```html

Yellowish Sclera After Medication

What is Yellowish sclera after medication?

Yellowish discoloration of the sclera (the white part of the eye) that appears after starting a new medication is a visible sign that something in the body’s metabolism or liver function may be altered. The sclera is normally bright white because it is made of dense connective tissue that does not contain pigment. When bilirubin – a yellow pigment produced by the breakdown of red blood cells – builds up in the bloodstream, it can deposit in the sclera, giving the eyes a gold‑en or amber hue. This condition is often referred to as “jaundice of the eyes.”

While a fleeting yellow tint may be harmless (e.g., after prolonged sun exposure), a persistent yellowish sclera that begins after a medication is started should prompt a focused evaluation, because it can signal drug‑induced liver injury, hemolysis, or other systemic problems.

Common Causes

Several medications and medical conditions can lead to yellowish sclera. The most frequent culprits include:

• Aminotransferase‑inducing antibiotics – e.g., amoxicillin‑clavulanate, ceftriaxone.
• Antitubercular drugs – especially isoniazid and rifampin.
• Antiepileptics – phenytoin, carbamazepine, valproic acid.
• Statins – high‑dose simvastatin, atorvastatin may cause mild liver enzyme rise.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – ibuprofen, naproxen (rare).
• Immunosuppressants – azathioprine, methotrexate.
• Herbal and dietary supplements – kava, green tea extracts, high‑dose vitamin A.
• Hemolytic conditions triggered by drugs – e.g., dapsone, primaquine.
• Underlying liver disease worsened by medication – chronic hepatitis, alcoholic liver disease.
• Rare metabolic disorders – Gilbert’s syndrome becomes apparent under drug stress.

Associated Symptoms

Yellow sclera rarely occurs in isolation. Look for other signs that often accompany bilirubin elevation or drug toxicity:

• Dark‑brown urine or pale‑colored stools.
• Itching (pruritus) without rash.
• Upper right‑abdominal discomfort or fullness.
• Fatigue, weakness, or loss of appetite.
• Nausea, vomiting, or unexplained weight loss.
• Fever, chills, or a rash suggestive of an allergic drug reaction.
• Bruising or easy bleeding (indicating impaired clotting).
• Swelling of the abdomen or legs (ascites, edema).
• Red or brown discoloration of the skin (especially on the palms and soles).

When to See a Doctor

Prompt medical evaluation is warranted if any of the following apply:

• The yellow tint appears within days to weeks after starting a new medication.
• Yellowing spreads to the skin (classic jaundice).
• You develop abdominal pain, especially in the upper right quadrant.
• New dark urine, pale stools, or severe itching occur.
• Persistent fatigue, vomiting, or unexplained weight loss.
• Signs of an allergic reaction – rash, swelling of the face/tongue, or difficulty breathing.
• Bleeding gums, easy bruising, or nosebleeds.

Because drug‑induced liver injury can progress quickly, never wait for the sclera to “clear up” on its own.

Diagnosis

Healthcare providers use a step‑wise approach to determine the cause of yellowish sclera.

1. Detailed History

• Medication list – prescription, over‑the‑counter, supplements, and herbal products.
• Timing of symptom onset relative to drug initiation.
• Alcohol intake, recent travel, exposure to hepatitis viruses.
• Past liver disease, family history of bilirubin disorders.

2. Physical Examination

• Inspect skin for jaundice, spider angiomas, or palmar erythema.
• Palpate the liver and spleen for enlargement.
• Assess for ascites, edema, and signs of chronic liver disease.

3. Laboratory Tests

• Liver function panel – ALT, AST, alkaline phosphatase, GGT, bilirubin (total & direct).
• Complete blood count – to assess hemolysis or infection.
• Coagulation profile – PT/INR; the liver produces clotting factors.
• Serum haptoglobin and LDH – markers of hemolysis.
• Viral hepatitis serologies (A, B, C) if indicated.

4. Imaging (when needed)

• Abdominal ultrasound – evaluates liver echotexture, biliary ducts, and gallbladder.
• CT or MRI if obstruction or mass is suspected.

5. Specialized Tests

• Drug‑induced liver injury (DILI) scoring systems (RUCAM).
• Genetic testing for Gilbert’s or Crigler‑Najjar syndrome in recurrent cases.

Treatment Options

Treatment is aimed at removing the offending agent, supporting liver function, and managing symptoms.

1. Discontinue or substitute the medication

• Most drug‑induced cases improve within 1–3 weeks after stopping the drug.
• Switch to an alternative with a safer hepatic profile (e.g., use azithromycin instead of amoxicillin‑clavulanate when appropriate).

2. Supportive care

• Hydration – oral or IV fluids to assist bilirubin clearance.
• Antipruritic measures – cholestyramine, antihistamines, or topical soothing creams.
• Nutrition – a balanced diet low in saturated fats and rich in antioxidants (fruits, vegetables).

3. Pharmacologic interventions (selected cases)

• N‑Acetylcysteine (NAC) – used for acetaminophen toxicity and, sometimes, for non‑acetaminophen DILI.
• Corticosteroids – considered for severe immune‑mediated drug reactions (e.g., drug‑induced hepatitis with eosinophilia).
• Ursodeoxycholic acid – may help in cholestatic patterns of liver injury.

4. Monitoring

• Repeat liver function tests every 48–72 hours until values trend downward.
• Long‑term follow‑up if bilirubin remains elevated >6 weeks, indicating possible chronic injury.

Prevention Tips

Most cases are preventable with careful medication management and lifestyle choices.

• Inform every prescriber about prior drug reactions and existing liver disease.
• Read medication leaflets for warnings about hepatic side effects.
• Avoid using multiple hepatotoxic agents simultaneously (e.g., combining high‑dose acetaminophen with isoniazid).
• Limit alcohol intake while on medications known to stress the liver.
• Use the lowest effective dose and shortest duration possible.
• Schedule routine liver‑function testing when starting high‑risk drugs (statins, antituberculars, antiepileptics).
• Prefer food‑grade supplements over concentrated herbal extracts unless a health‑care professional advises otherwise.
• Maintain a healthy weight – obesity increases the risk of non‑alcoholic fatty liver disease, which can magnify drug toxicity.

Emergency Warning Signs

References

1. Mayo Clinic. Jaundice. Accessed May 2026.
2. American College of Gastroenterology. Drug‑Induced Liver Injury. Guidelines.
3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Drug‑Induced Liver Injury. 2024.
4. World Health Organization (WHO). Jaundice Fact Sheet. 2023.
5. Cleveland Clinic. What Is Jaundice? 2025.
6. LiverTox: Clinical and Research Information on Drug‑Induced Liver Injury, NIH. Online Resource. Updated 2024.

```